UBS Group
SHACW

UBS Group’s SCP & CO Healthcare Acquisition Company Warrant SHACW Stock Holding History

UBS Group’s Portfolio SHACW Stock Details SHACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-264
Closed – – 11737
2022
Q3 		$0 Buy
264
+100
+61% +$5 ﹤0.01% 11554
2022
Q2 		$0 Buy
164
+100
+156% +$14 ﹤0.01% 11514
2022
Q1 		$0 Sell
64
-1
-2% – ﹤0.01% 11382
2021
Q4 		$0 Sell
65
-1,710
-96% -$1.01K ﹤0.01% 11129
2021
Q3 		$1K Sell
1,775
-574
-24% -$406 ﹤0.01% 9383
2021
Q2 		$2K Sell
2,349
-665
-22% -$425 ﹤0.01% 9057
2021
Q1 		$2K Buy
+3,014
New +$1.85K ﹤0.01% 8691

UBS Group's SHACW Position: Q4 2022 in Review

UBS Group sold out of SCP & CO Healthcare Acquisition Company Warrant (SHACW) in Q4 2022, closing a stake of 264 shares.

UBS Group first reported a position in SHACW in Q1 2021 and held it in 7 quarters. The position peaked at $2K in Q2 2021. 0 funds tracked by Wall St. Rank hold SHACW as of Q4 2022.

  • UBS Group reported no remaining SCP & CO Healthcare Acquisition Company Warrant position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 264 SCP & CO Healthcare Acquisition Company Warrant shares in Q4 2022.
  • UBS Group first reported a position in SCP & CO Healthcare Acquisition Company Warrant in Q1 2021 and held it in 7 quarters.
  • UBS Group's SCP & CO Healthcare Acquisition Company Warrant position peaked at $2K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Warrant as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.